Head-to-head comparison of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in advanced pancreatic cancer: a target trial emulation using real-world data
Devon J. Boyne, Darren R. Brenner, Alind Gupta, E. V. Mackay, Paul Arora, Radek Wasiak, Winson Y. Cheung, Miguel A. Hernán
Topics & Concepts
MedicineFOLFIRINOXGemcitabineOxaliplatinHazard ratioInternal medicineIrinotecanFolinic acidPopulationPancreatic cancerConfidence intervalOncologySurgeryFluorouracilCancerColorectal cancerEnvironmental healthPancreatic and Hepatic Oncology ResearchCholangiocarcinoma and Gallbladder Cancer StudiesGastric Cancer Management and Outcomes